How to Maximize Valuation for Minimal Cost

Collaboration Between Contract Research Organizations and Biotech Companies

Wrap up our Driving Productivity in Biotech Clinical Trials podcast as we discuss collaboration between Contract Research Organizations and biotech companies, emphasizing the importance of communication and understanding in clinical trials. Participants: Host: Dr. Ken Park, VP of R&D Strategy and Innovation Consulting for Fortrea Tracy Newbold, VP of Clinical Operations at Lexicon Pharmaceuticals Terry Athreya, SVP and Global Head of Clinical Operations for Fortrea Alaric Jackson, Chief Technology and Data Officer at Fortrea

Innovative Approaches to Enhance Productivity

This episode explores innovative approaches to enhance productivity within clinical trials, focusing on the use of technology and data-driven strategies. Participants: Host: Dr. Ken Park, VP of R&D Strategy and Innovation Consulting for Fortrea Tracy Newbold, VP of Clinical Operations at Lexicon Pharmaceuticals Terry Athreya, SVP and Global Head of Clinical Operations for Fortrea Alaric Jackson, Chief Technology and Data Officer at Fortrea

How to Maximize Valuation for Minimal Cost

In this episode, “How to Maximize Valuation for Minimal Cost,” we explore a critical question: Are you focused on regulatory approval, or on maximizing value? Your answer could determine the path your clinical trial takes, and the outcome it delivers. Participants: Host: Dr. Ken Park, VP of R&D Strategy and Innovation Consulting for Fortrea Tracy Newbold, VP of Clinical Operations at Lexicon Pharmaceuticals Terry Athreya, SVP and Global Head of Clinical Operations for Fortrea Alaric Jackson, Chief Technology and Data Officer at Fortrea